Epigenetic silencing of miR-137 induces resistance to bicalutamide by targeting TRIM24 in prostate cancer cells

Prostate cancer is an important hormone-dependent cancer affecting men. In the initial stages, prostate cancer is often treated using hormone therapy, including bicalutamide. Despite the initial effectiveness of this therapy, the tumor eventually acquires resistance, resulting in recurrence of castr...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Am J Transl Res
Huvudupphovsmän: Guan, Yonghui, Guan, Xiaoyue, An, Hengqing, Baihetiya, Azhati, Wang, Wenguang, Shao, Weimin, Yang, Haiou, Wang, Yujie
Materialtyp: Artigo
Språk:Inglês
Publicerad: e-Century Publishing Corporation 2019
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6556665/
https://ncbi.nlm.nih.gov/pubmed/31217891
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk